October 2024

A listing of the individual articles included in the Jurisdiction F Medicare B News bulletin dated October 2024 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
2024 Annual Update of HCPCS Codes for SNF CB Update CR13394
2024 CPT/HCPCS Local Coverage Article (LCA) Updates
2024 ICD-10 Billing and Coding Article Updates - Effective October 1, 2024
2024 Q4 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective October 1, 2024
2024 Q4 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective October 1, 2024
2025 Medicare Physician Fee Schedule Now Available
Ambulatory Surgical Center Payment Update - July 2024 - Revised CR13656
Ambulatory Surgical Center Payment Update - October 2024 - Revised CR13800
Annual Update of HCPCS Codes Used for Home Health Consolidated Billing Enforcement CR13732
Annual Wellness Visit: SDOH Risk Assessment - Revised CR13486
Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA) Final LCD - Effective December 8, 2024
Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs) (A57162) - R4 - Effective October 1, 2015
Billing and Coding MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R19 - Effective August 1, 2024
Billing and Coding: Cervical Fusion (A59645) - R2 - Effective September 29, 2024
Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP) A58225 - R3 - Effective September 15, 2024
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R17 - Effective July 1, 2024
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R18 - Effective October 1, 2024
Billing and Coding: Lab: Cystatin C Measurement (A57644) - R5 - Effective January 1, 2023
Billing and Coding: Lab: Flow Cytometry (A57690) - R11 - Effective October 1, 2024
Billing and Coding: MolDX: Afirma™ Assay by Veracyte (A54358) Retirement - Effective July 28, 2024
Billing and Coding: MolDX: BCR-ABL (A55600)- R5 - Effective September 19, 2024
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update (A54388) - R11 - Effective October 1, 2024
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (A57376) - R5 - Effective October 1, 2024
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57422) - R11 - Effective October 1, 2024
Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (A57424) - R4 - Effective November 7, 2024
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681) - R6 - Effective August 1, 2024
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681) - R7 - Effective October 1, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58997) - R6 - Effective October 1, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58997) - R7 - Effective October 1, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58997) - R8 - Effective July 11, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R7 - Effective July 11, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456)- R8 - Effective September 26, 2024
Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (A59522) - R2 - Effective July 1, 2024
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58724) - R4 - Effective November 28, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R19 - Effective July 1, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R18 - Effective July 1, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726)- R20 - Effective October 1, 2024
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57892) - R8 - Effective October 1, 2024
Billing and Coding: MolDX: Pharmacogenomics Testing (A57385) - R14 - Effective August 1, 2024
Billing and Coding: MolDX: Proteomics Testing (A59642) - R5 - Effective July 1, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57332) - R12 - Effective July 1, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57332) - R13 - Effective September 5, 2024
Billing and Coding: Peripheral Nerve Stimulation (A55531) - R9 - Effective October 1, 2024
Billing and Coding: Respiratory Care (A57225) - R15 - Effective October 1, 2024
Billing Tips for Psychotherapy with Evaluation & Management (E/M)
Cardiac and Pulmonary Rehab Place of Service (POS) 10 Denials - Resolved 09/26/24 Alert
Changes to the Laboratory NCD Edit Software: January 2025 Update CR13785
Changes to the Laboratory NCD Edit Software: October 2024 Update CR13672
Changes to Value-Based Insurance Design Model: CY 2024 CR13236
CLIA Lab B7 Denials - Resolved 08/29/24 Alert
— 50 Items per Page
Showing 1 - 50 of 149 results.